We next explored molecular mechanisms underlying the effect of METTL3 in NAFLD-HCC and showed that METTL3-mediated immune suppression in NAFLD-HCC depends on the regulation of cholesterol metabolism. The gene discussed is METTL3; the disease is hepatocellular carcinoma.